Genes regulating implantation and fetal development: A focus on mouse knockout models

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2123-2137

  Sharma, Surendra ^a   Murphy, Shaun P ^a   Barnea, Eytan R ^b,c  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b Society for the Investigation of Early Pregnancy   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Blastocyst implantation; Cytokine; Fetal development; Gene knockout; IGFBP ; Insulin growth factor; LIF; MMP; NK cell; Review

Indexed keywords

ANIMALIA; MAMMALIA;

EID: 33744750190     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1955     Document Type: Review

References (194)

1. Vigano P, Mangioni S, Pompei F, and Chiodo I. Maternal-conceptus cross talk-a review. Placenta 24, Suppl B:S56-61 (2003)
2. Dominguez F, Pellicer A, and Simon C. The chemokine connection: hormonal and embryonic regulation at the human maternal-embryonic interface-a review. Placenta 24 Suppl B:S48-55 (2003)
3. Saito S. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 52, 15-33 (2001)
4. Wegmann TG. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr Opin Immunol 2, 765-69 (1989)
5. Paria BC, Reese J, Das SK, Dey SK. Deciphering the cross-talk of implantation: advances and challenges. Science 21, 2185-2188 (2002)
6. Simon C, Mercader A, Gimeno MJ, Pellicer A. The interleukin-1 system and human implantation. Am J Reprod Immunol 37, 64-72 (1997)
7. Aghajanova L. Leukemia inhibitory factor and human embryo implantation. Ann N Y Acad Sci 1034, 176-183 (2004)
8. Barnea ER. Insight into early pregnancy events: the emerging role of the embryo. Am J Reprod Immunol 51, 1-4 (2004)
9. Rosario GX, Modi DN, Sachdeva G, Manjramkar DD, Puri CP. Morphological events in the primate endometrium in the presence of a preimplantation embryo, detected by the serum preimplantation factor bioassay. Hum Reprod 20, 61-71 (2005)
10. Evain-Brion D. Hormonal regulation of fetal growth. Horm Res 42, 207-214 (1994)
11. Anthony RV, Pratt SL, Liang R, Holland MD. Placental-fetal hormonal interactions: impact on fetal growth. J Anim Sci 73, 1861-1871 (1995)
12. Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res Suppl 1, 11-16 (1997)
13. Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine 19, 13-22 (2002)
14. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23, 3-19 (2002)
15. Godfrey KM. Maternal regulation of fetal development and health in adult life. Eur J Obstet Gynecol Reprod Biol 78, 141-150 (1998)
16. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122, 1723-1736 (1996)
17. Sharkey ME, Adler RR, Nieder GL, Brenner CA. Matrix metalloproteinase expression during mouse peri-implantation development. Am J Reprod Immunol 36, 72-80 (1996)
18. Das SK, Yano S, Wang J, Edwards DR, Nagase H, Dey SK. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev Genet 21, 44-54 (1997)
19. Ashkar AA, Croy BA. Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol 13, 235-241 (2001)
20. Ain R, Canham LN, Soares MJ. Gestation stage-dependent intrauterine trophoblast cell invasion in the rat and mouse: novel endocrine phenotype and regulation. Dev Biol 260, 176-190 (2003)
21. Cadet P, Rady PL, Tyring SK, Yandell RB, Hughes TK. Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol 173, 25-29 (1995)
22. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med. 184, 539-548 (1996)
23. Bennett WA, Lagoo-Deenadayalan S, Whitworth NS, Brackin MN, Hale E, Cowan BD. Expression and production of interleukin-10 by human trophoblast: relationship to pregnancy immunotolerance. Early Pregnancy 3, 190-198 (1997)
24. Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ. Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 4, 247-253 (1997)
25. Dudley DJ, Edwin SS, Dangerfield A, Jackson K, Trautman MS. Regulation of decidual cell and chorion cell production of interleukin-10 by purified bacterial products. Am J Reprod Immunol 38, 246-251 (1997)
26. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 164, 5721-5728 (2000)
27. Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN. Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 46, 386-92 (2001)
28. Reese J, Das SK, Paria BC, Lim H, Song H, Matsumoto H, Knudtson KL, DuBois RN, Dey SK. Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem 276, 44137-44145 (2001)
29. Lobo SC, Huang ST, Germeyer A, Dosiou C, Vo KC, Tulac S, Nayak NR, Giudice LC. The immune environment in human endometrium during the window of implantation. Am J Reprod Immunol 52, 244-251 (2004)
30. Riesewijk A, Martin J, van Roselinde Os, Horcajadas JA, Polman J, Pellicer A, Mosselman S, Simon C. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 9, 253-264 (2003)
31. Julkunen M, Raikar RS, Joshi SG, Bohn H, Seppala M. Placental protein 14 and progestagen-dependent endometrial protein are immunologically indistinguishable. Hum Reprod 1, 7-8 (1986)
32. Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR, Lessey BA. Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 86, 4991-5000 (2001)
33. Zhou J, Dsupin BA, Giudice LC, Bondy CA. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 79, 1723-1734 (1994)
34. Popovici RM, Kao LC, Giudice LC. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology 141, 3510-3513 (2000)
35. Gruidl M, Buyuksal A, Babaknia A, Fazleabas AT, Sivarajah S, Satyawaroop PG, Tabibzadeh S. The progressive rise in the expression of alpha crystallin B chain in human endometrium is initiated during the implantation window: modulation of gene expression by steroid hormones. Mol Hum Reprod 3, 333-342 (1997)
36. Chen HW, Chen JJ, Tzeng CR, Li HN, Chang SJ, Cheng YF, Chang CW, Wang RS, Yang PC, Lee YT. Global analysis of differentially expressed genes in early gestational decidua and chorionic villi using a 9600 human cDNA microarray. Mol Hum Reprod 8, 475-484 (2002)
37. Tanaka TS, Ko MS. A global view of gene expression in the preimplantation mouse embryo: morula versus blastocyst. Eur J Obstet Gynecol Reprod Biol 115, S85-91 (2004)
38. Hamatani T, Daikoku T, Wang H, Matsumoto H, Carter MG, Ko MS, Dey SK. Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proc Natl Acad Sci U S A 101, 10326-10331 (2004)
39. Dobson AT, Raja R, Abeyta MJ, Taylor T, Shen S, Haqq C, Pera RA. The uniquetranscriptome through day 3 of human preimplantation development. Hum Mol Genet 13, 1461-1470 (2004)
40. Tanaka TS, Jaradat SA, Lim MK, Kargul GJ, Wang X, Grahovac MJ, Pantano S, Sano Y, Piao Y, Nagaraja R, Doi H, Wood WH 3rd, Becker KG, Ko MS. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci U S A 97, 9127-9132 (2000)
41. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 8, 1314-1325 (1994)
42. Sims JE, Giri JG, Dower SK. The two interleukin-1 receptors play different roles in IL-1 actions. Clin Immunol Immunopathol 72, 9-14 (1994)
43. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 25, 336-340 (1990)
44. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343, 341-346 (1990)
45. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 173, 931-939 (1991)
46. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266, 10331-10336 (1991)
47. Simon C, Frances A, Piqutte GN, Heindrickson M, Milki A, Polan ML. Interleukin-1 system in the maternotrophoblast unit in human implantation: Immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab 78, 847-854 (1994)
48. Simon C, Frances A, Lee BY, Mercader A, Huynh T, Remohi J, Polan ML, Pellicer A. Immunohistochemical localization, identification and regulation of the interleukin-1 receptor antagonist in the human endometrium. Hum Reprod 10, 2472-2477 (1995)
49. Liang L, Kover K, Dey SK, Andrews GK. Regulation of interleukin-6 and interleukin-1 beta gene expression in the mouse deciduum. J Reprod Immunol 30, 29-52 (1996)
50. Takacs P, Kauma S. The expression of interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor type I mRNA during preimplantation mouse development. J Reprod Immunol 32, 27-35 (1996)
51. Simon C, Mercader A, Gimeno MJ, Pellicer A. The interleukin-1 system and human implantation. Am J Reprod Immunol 37, 64-72 (1997)
52. Krussel JS, Simon C, Rubio MC, Pape AR, Wen Y, Huang HY, Bielfeld P, Polan ML. Expression of interleukin-1 system mRNA in single blastomeres from human preimplantation embryos. Hum Reprod 13, 2206-2211 (1998)
53. Tanaka T, Sakamoto T, Mizuno K, Umesaki N, Ogita S. Human endometrial stromal interleukin-1 beta: autocrine secretion and inhibition by interleukin-1 receptor antagonist. Horm Res 53, 300-304 (2000)
54. Bigonnesse F, Labelle Y, Akoum A. Triphasic expression of interleukin-1 receptor type I in human endometrium throughout the menstrual cycle of fertile women and women with unexplained infertility. Fertil Steril 75, 79-87 (2001)
55. Simon C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, Polan ML. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 134, 521-528 (1994)
56. Hirsch E, Blanchard R, Mehta SP. Differential fetal and maternal contributions to the cytokine milieu in a murine model of infection-induced preterm birth. Am J Obstet Gynecol 180, 429-434 (1999)
57. Simon C, Frances A, Piquette GN, el DI, Zurawski G, Dang W, and Polan ML. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 134, 521-528 (1994)
58. Abbondanzo SJ, Cullinan EB, McIntyre K, Labow MA, Stewart CL. Reproduction in mice lacking a functional type 1 IL-1 receptor. Endocrinology 137, 3598-5601 (1996)
59. Taga T, Kishmoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15, 797-819 (1997)
60. Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF. Leukemia inhibitory factor: part of a large ingathering family. Int Rev Immunol 16, 397-426 (1998)
61. Gearing DP, Thut CJ, VandeBos T, Gimpel SD, Delaney PB, King J, Price V, Cosman D, Beckmann MP. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 10, 2839-2848 (1991)
62. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, et al. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 179, 1337-1342 (1994)
63. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 80, 1908-1915 (1995)
64. Wetzler M, Talpaz M, Lowe DG, Baiocchi G, Gutterman JU, Kurzrock R. Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta. Exp Hematol 19, 347-351 (1991)
65. Schluns KS, Cook JE, Le PT. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. J Immunol 158, 2704-2712 (1997)
66. Matsuoka I, Nakane A, Kurihara K. Induction of LIF-mRNA by TGF-beta 1 in Schwann cells. Brain Res 776, 170-180 (1997)
67. Yang ZM, Chen DB, Le SP, Harper MJ. Differential hormonal regulation of leukemia inhibitory factor (LIF) in rabbit and mouse uterus. Mol Reprod Dev 43, 470-476 (1996)
68. Bhatt H, Brunet LJ, Stewart CL. Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci U S A 88, 11408-11412 (1991)
69. Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, Patel DD, Haynes BF. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 164, 2180-2187 (2000)
70. McKenzie RC, Szepietowski JC. Leukaemia inhibitory factor (LIF) expression in skin from amyotrophic lateral sclerosis patients compared with skin from normal individuals: what is the function of LIF in the skin? J Invest Dermatol 116, 476-478 (2001)
71. Ni H, Ding NZ, Harper MJ, Yang ZM. Expression of leukemia inhibitory factor receptor aid gp130 in mouse uterus during early pregnancy. Mol Reprod Dev 63, 143-150 (2002)
72. Robertson M, Chambers I, Rathjen P, Nichols J, Smith A. Expression of alternative forms of differentiation inhibiting activity (DIA/LIF) during murine embryogenesis and in neonatal and adult tissues. Dev Genet 14, 165-173 (1993)
73. Blancho G, Moreau JF, Chabannes D, Chatenoud L, Soulillou JP. HILDA/LIF, G.CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts. Transplantation 56, 597-602 (1993)
74. Tomida M, Yamamoto-Yamaguchi Y, Hozumi M. Pregnancy associated increase in mRNA for soluble D factor/LIF receptor in mouse liver. FEBS Lett 334, 193-197 (1993)
75. Knight DA, Lydell CP, Zhou D, Weir TD, Schellenberg R, Bai TR. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am J Respir Cell Mol Biol. 20, 834-41 (1999)
76. Jougasaki M, Leskinen H, Larsen AM, Cataliotti A, Chen HH, Burnett JC Jr. Leukemia inhibitory factor is augmented in the heart in experimental heart failure. Eur J Heart Fail 5, 137-145 (2003)
77. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells 21, 5-14 (2003)
78. Shen MM, Leder P. Leukemia inhibitory factor B expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci U S A 89, 8240-8244 (1992)
79. Kojima K, Kanzaki H, Iwai M, Hatayama H, Fujimoto M, Inoue T, Hone K, Nakayama H, Fujita J, Mori T. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol Reprod 50, 882-887 (1994)
80. Yang ZM, Le SP, Chen DB, Cota J, Siero V, Yasukawa K, Harper MJ. Leukemia inhibitory factor, LIF receptor, and gp130 in the mouse uterus during early pregnancy. Mol Reprod Dev 42, 407-414 (1995)
81. bright natural killer cells in the human early pregnancy deciduas. Int Immunol 5, 559-563 (1993)
82. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 4, 1020-1024 (1998)
83. Song H, Lim H, Das SK, Paria BC, and Dey SK. Dysregulation of EGF family of growth factors and COX-2 in the uterus of preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Molecular Endocrinology. 14, 1147-1161 (2000)
84. Arici A, Engin O, Attar E, Olive DL. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J. Clin. Endocrinol Metab. 80, 1908-1915 (1995)
85. Nachtigall MJ, Kliman HJ, Feinberg RF, Olive DL, Engin O, Arici A. The effect of leukemia inhibitory factor (LIF) on trophoblast differentiation: a potential role in human reproduction. J. Clin. Endocrinol. Metab. 81, 801-806 (1996)
86. Stewart CL, Kasper P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, and Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 359, 76-79 (1992)
87. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papaynnopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural, and metabolic defects and results in perinatal death. Development 121, 1283-1299 (1995)
88. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin-6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci. USA 93, 407-411 (1996)
89. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 12, 569-574 (1997)
90. Giess R, Tanasecu I, Steck T, Sendtner M. Leukemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 5, 581-586 (1999)
91. Steck T, Giess R, Suetterlin MW, Bolland M, Wiest S, Poehls UG, Dietl J. Leukemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer. Eur J Obstet Gynecol Reprod Biol 112, 69-73 (2004)
92. Robbinson RC, Grey LM, Staunton D, Vankelecom H, Vernallis AB, Moreau JF, Stuart DI, Heath JK, Jones EY. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 77, 1101-1116 (1994)
93. Sherwin JR, Freeman TC, Stephens RJ, Kimber S, Smith AG, Chambers I, Smith SK, Sharkey AM. Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. Mol Endocrinol 18, 2185-2195 (2004)
94. Sawai K, Matsuzaki N, Kameda T, Hashimoto K, Okada T, Shimoya K, Nobunaga T, Taga T, Kishimoto T, Saji F. Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: its possible implication during pregnancy, including implantation period. J Clin Endocrinol Metab 80, 1449-1456 (1995)
95. Harvey MB, Leco KJ, Arcellana-Panlilio MY, Zhang X, Edwards DR, Schultz GA. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 121, 1005-1014 (1995)
96. Sands BE, Bank S, Sninsky CA, Robinson M, Katz S, Singleton JW, Miner PB, Safdi MA, Galandiuk S, Hanauer SB, Varilek GW, Buchman AL, Rodgers VD, Salzberg B, Cai B, Loewy J, DeBruin MF, Rogge H, Shapiro M, Schwertschlag US. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology 117, 58-64 (1999)
97. Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 12, 79-87 (1994)
98. Neben S, Turner K. The biology of interleukin 11. Stem Cells 11, 156-162 (1993)
99. Cork BA, Li TC, Warren MA, Laird SM. Interleukin-11 (IL-11) in human endometrium: expression throughout the menstrual cycle and the effects of cytokines on endometrial IL-11 production in vitro. J Reprod Immunol 50, 3-17 (2001)
100. Zourbas S, Dubanchet S, Martal J, Chaouat G. Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the foetomaternal interface during murine pregnancy. Clin Exp Immunol 126, 519-528 (2001)
101. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 4, 303-308 (1998)
102. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH. CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 21, 151-159 (1983)
103. Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER. Apparent role of the macrophage growth factor, CSF-1, in placental development. Nature 330, 484-486 (1987)
104. Arceci RJ, Shanahan F, Stanley ER, Pollard JW. Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci U S A 86, 8818-8822 (1989)
105. Kauma SW, Aukerman SL, Eierman D, Turner T. Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy. J Clin Endocrinol Metab 73, 746-751 (1991)
106. Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 148, 273-283 (1991)
107. Katano K, Matsumoto Y, Ogasawara M, Aoyama T, Ozaki Y, Kajiura S, Aoki K. Low serum M-CSF levels are associated with unexplained recurrent abortion. Am J Reprod Immunol 38, 1-5 (1997)
108. Boehm, U., Klamp T., Groot M., Howard JC. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15, 749-795 (1997)
109. Plevyak M, Hanna N, Mayer S, Murphy S, Pinar H, Fast L, Ekerfelt C, Ernerudh J, Berg G, Matthiesen L, Sharma S. Deficiency of decidual IL-10 in first trimester missed abortion: a lack of correlation with the decidual immune cell profile. Am J Reprod Immunol 47, 242-250 (2002)
110. Vassiliadis, S., D. Tsoukatos, and I. Athanassakis. Interferon-induced class II expression at the spongiotrophoblastic zone of the murine placenta is linked to fetal rejection and developmental abnormalities. Acta. Physiol. Scand 151, 485-495 (1994)
111. Ashkar AA, Croy BA. Interferon-gamma contributes to the normalcy of murine pregnancy. Biol Reprod. 61, 493-502 (1999)
112. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 683-765 (2001)
113. Wu MY, Chen HF, Chen SU, Chao KH, Yang YS, Ho HN. Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy. Am J Reprod Immunol 46, 386-392 (2001)
114. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 151, 4562-4573 (1993)
115. Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ. Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 4, 247-253 (1997)
116. Rieger L, Hofmeister V, Probe C, Dietl J, Weiss EH, Steck T, Kammerer U. Th1- and Th2-like cytokine production by first trimester decidual large granular lymphocytes is influenced by HLA-G and HLA-E. Mol Hum Reprod 8, 255-61 (2002)
117. Piccinni MP. T-cell cytokines in pregnancy. Am J Reprod Immunol 2002 47, 289-294.
118. Nagaeva O, Jonsson L, Mincheva-Nilsson L. Dominant IL-10 and TGF-beta mRNA expression in gammadeltaT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 48, 9-17 (2002)
119. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 48, 77-86 (2002)
120. Lidstrom C, Matthiesen L, Berg G, Sharma S, Ernerudh J, Ekerfelt C. Cytokine secretion patterns of NK cells and macrophages in early human pregnancy decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol 50, 444-452 (2003)
121. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 11, 803-811 (1999)
122. Rizzo R, Hviid TV, Stignani M, Balboni A, Grappa MT, Melchiorri L, Baricordi OR. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics. 57, 172-181 (2005)
123. Kundu N, Fulton AM. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Cell Immunol 180, 55-61 (1997)
124. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A 94, 5249-5254 (1997)
125. Adrian Cabestre F, Moreau P, Riteau B, Ibrahim EC, Le Danff C, Dausset J, Rouas-Freiss N, Carosella ED, Paul P. HLA-G expression in human melanoma cells: protection from NK cytolysis. J Reprod Immunol 43, 183-193 (1999)
126. Park GM, Lee S, Park B, Kim E, Shin J, Cho K, Ahn K. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 313, 606-611 (2004)
127. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrino. 2, 59 (2004)
128. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96, 2304-2310 (1995)
129. Roth I, Fisher SJ. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 205, 194-204 (1999)
130. Yamamoto-Tabata T, McDonagh S, Chang HT, Fisher S, Pereira L. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol 78, 2831-2840 (2004)
131. Hill JA, Polgar K, Anderson DJ. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273, 1933-1936 (1995)
132. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 196, 122-130 (1999)
133. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 163, 3491-3495 (1999)
134. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Goarzelak B, Oleszczuk J. The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 48, 381-386 (2002)
135. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi JA, Al-Azemi MM. Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 49, 308-318 (2003)
136. Rein DT, Breidenbach M, Honscheid B, Friebe-Hoffmann U, Engel H, Gohring UJ, Uekermann L, Kurbacher CM, Schondorf T. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 23, 119-125 (2003)
137. Peltier MR. Immunology of term and preterm labor. Reprod Biol Endocrinol 1, 122 (2003)
138. Hossein H, Mahroo M, Abbas A, Firouzeh A, Nadia H. Cytokine production by peripheral blood mononuclear cells in recurrent miscarriage. Cytokine 28, 83-86 (2004)
139. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliot J, Mosmann T, Wegmann TG. IL-10 prevents naturally occurring fetal loss in the CBA x DBA/2 mating combination, and local defect in EL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-tau. J Immunol 154, 4261-4268 (1995)
140. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol Reprod 10, 123-123 (2004)
141. Roberts CT, White CA, Wiemer NG, Ramsay A, Robertson SA. Altered placental development in interleukin-10 null mutant mice. Placenta 24, S94-99 (2003)
142. Majerus PW. Prostaglandins: critical roles in pregnancy and colon cancer. Curr Biol 8, R87-89 (1998)
143. Slater DM, Zervou S, Thornton S. Prostaglandins and prostanoid receptors in human pregnancy and parturition. J Soc Gynecol Investig 9, 118-24 (2002)
144. Saito S, Tsuda H, Michimata T. Prostaglandin D2 and reproduction. Am J Reprod Immunol. 47, 295-302 (2002)
145. Adelizzi RA. COX-1 and COX-2 in health and disease. J Am Osteopath Assoc 99, S7-12 (1999)
146. McCormack K. Roles of COX-1 and COX-2. J Rheumatol 25, 2279-2281 (1998)
147. Marnett LJ, Rowlinson SW, Goodwin DC, Kalgutkar AS, Lanzo CA. Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J Biol Chem 274, 22903-22906 (1999)
148. Marions L, Danielsson KG. Expression of cyclooxygenase in human endometrium during the implantation period. Mol Hum Reprod 5, 961-965 (1999)
149. Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM, Dey SK. Cyclooxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 13, 1561-1574 (1999)
150. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91, 197-208 (1997)
151. Silver RM, Edwin SS, Trautman MS, Simmons DL, Branch DW, Dudley DJ, Mitchell MD. Bacterial lipopolysaccharide-mediated fetal death. Production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J Clin Invest 95, 725-731 (1995)
152. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, Muglia LJ. Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 278, R1415-1423 (2000)
153. Akarasereenont P, Techatraisak K, Chotewuttakorn S, Thaworn A. The expression of cyclooxygenase-2 in human umbilical vein endothelial cell culture from preeclampsia. J Med Assoc Thai;82, 167-172 (1999)
154. Ota H, Igarashi S, Sasaki M, Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16, 561-566 (2001)
155. Chishima F, Hayakawa S, Sugita K, Kinukawa N, Aleemuzzaman S, Nemoto N, Yamamoto T, Honda M. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 48, 50-56 (2002)
156. Loudon JA, Groom KM, Bennett PR. Prostaglandin inhibitors in preterm labour. Best Pract Res Clin Obstet Gynaecol 17, 731-744 (2003)
157. Fagotti A, Ferrandina G, Fanfani F, Legge F, Lauriola L, Gessi M, Castelli P, Barbieri F, Minelli L, Scambia G. Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico pathological parameters. Hum Reprod 19, 393-397 (2004)
158. Hanna N, Bonifacio L, Reddy P, Hanna I, Weinberger B, Murphy S, Laskin D, Sharma S. IFN-gamma-mediated inhibition of COX-2 expression in the placenta from term and preterm labor pregnancies. Am J Reprod Immunol 51, 311-318 (2004)
159. van Kleffens M, Groffen C, Lindenbergh-Kortleve DJ, van Neck JW, Gonzalez-Parra S, Dits N, Zwarthoff EC, Drop SL. The IGF system during fetal-placental development of the mouse. Mol Cell Endocrinol. 140, 129-135 (1998)
160. Collett-Solberg PF, Cohen P. Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 12, 121-136 (2000)
161. Nayak NR, Giudice LC. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 24, 281-296 (2003)
162. Oka Y, Rozek LM, Czech MP. Direct demonstration of rapid insulin-like growth factor II Receptor internalization and recycling in rat adipocytes. Insulin stimulates 125I-insulin-like growth factor II degradation by modulating the IGF-II receptor recycling process. J Biol Chem 260, 9435-9442 (1985)
163. Czech MP. Signal transmission by the insulin-like growth factors. Cell 59, 235-238 (1989)
164. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20, 761-787 (1999)
165. Tang XM, Rossi MJ, Masterson BJ, Chegini N. Insulin-like growth factor I (IGF-I), IGF-I receptors, and IGF binding proteins 1-4 in human uterine tissue: tissue localization and IGF-I action in endometrial stromal and myometrial smooth muscle cells in vitro. Biol Reprod 50, 1113-1125 (1994)
166. Henemyre C, Markoff E. Expression of insulin-like growth factor binding protein-4, insulin-like growth factor-I receptor, and insulin-like growth factor-I in the mouse uterus throughout the estrous cycle. Mol Reprod Dev 52, 350-359 (1999)
167. Talavera F, Reynolds RK, Roberts JA, Menon KM. Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res 50, 3019-3024 (1990)
168. Rutanen EM. Insulin-like growth factors in endometrial function. Gynecol Endocrinol 12, 399-406 (1998)
169. Giudice LC. Multifaceted roles for IGFBP-1 in human endometrium during implantation and pregnancy. Ann N Y Acad Sci 828, 146-56 (1997)
170. Markoff E, Henemyre C, Fellows J, Pennington E, Zeitler PS, Cedars MI. Localization of insulin-like growth factor binding protein-4 expression in the mouse uterus during the peri-implantation period. Biol Reprod 53, 1103-1109 (1995)
171. Han VK, Carter AM. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta 21, 289-305 (2000)
172. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72 (1993)
173. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345, 78-80 (1990)
174. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417, 945-948 (2002)
175. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24, 428-465 (2003)
176. Seval Y, Akkoyunlu G, Demir R, Asar M. Distribution patterns of matrix metalloproteinase (MMP)-2 and -9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy. Acta Histochem 106, 353-362 (2004)
177. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL, Fisher SJ. Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 269, 17125-17131 (1994)
178. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96, 2304-2310 (1995)
179. Roth I, Fisher SJ. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 205, 194-204 (1999)
180. Stearns ME, Rhim J, Wang M. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion. Clin Cancer Res 5, 189-196 (1999)
181. Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell 6, 851-869 (1995)
182. Rudolph-Owen LA, Hulboy DL, Wilson CL, Mudgett J, Matrisian LM. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 138, 4902-4911 (1997)
183. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422 (1998)
184. Dubois B, Arnold B, Opdenakker G. Gelatinase B deficiency impairs reproduction. J Clin Invest 106, 627-628 (2000)
185. Soloway PD, Alexander CM, Werb Z, Jaenisch R. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host. Oncogene 13, 2307-2314 (1996)
186. Nothnick WB. Reduction in reproductive lifespan of tissue inhibitor of metalloproteinase 1 (TIMP-1)-deficient female mice. Reproduction 122, 923-927 (2001)
187. Riley P, Anson-Cartwright L, Cross JC. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 18, 271-275 (1998)
188. Scott IC, Anson-Cartwright L, Riley P, Reda D, Cross JC. The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms. Mol Cell Bio. 20, 530-541 (2000)
189. Basyuk E, Cross JC, Corbin J, Nakayama H, Hunter P, Nait-Oumesmar B, Lazzarini RA. Murine Gcm1 gene is expressed in a subset of placental trophoblast cells. Dev Dyn 214, 303-311 (1999)
190. Anson-Cartwright L, Dawson K, Holmyard D, Fisher SJ, Lazzarini RA, Cross JC. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet 25, 311-314 (2000)
191. Mellor AL, Chandler P, Lee GK, Johnson T, Keskin DB, Lee J, Munn DH. Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy. J Reprod Immunol Oct- 57, 143-150 (2002)
192. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191-1193 (1998)
193. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2, 64-68 (2001)
194. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 61, 67-77 (2004)